223 related articles for article (PubMed ID: 37013112)
1. Factors associated with receipt of COVID-19 vaccination and SARS-CoV-2 seropositivity among healthcare workers in Albania (February 2021-June 2022): secondary analysis of a prospective cohort study.
Jorgensen P; Schmid A; Sulo J; Preza I; Hasibra I; Kissling E; Fico A; Sridhar S; Rubin-Smith JE; Kota M; Vasili A; Daja R; Nika M; Pebody R; Lafond KE; Katz MA; Bino S
Lancet Reg Health Eur; 2023 Apr; 27():100584. PubMed ID: 37013112
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.
Recanatini C; GeurtsvanKessel CH; Pas SD; Broens EM; Maas M; van Mansfeld R; Mutsaers-van Oudheusden AJG; van Rijen M; Schippers EF; Stegeman A; Tami A; Veldkamp KE; Visser H; Voss A; Wegdam-Blans MCA; Wertheim HFL; Wever PC; Koopmans MPG; Kluytmans JAJW; Kluytmans-van den Bergh MFQ;
Antimicrob Resist Infect Control; 2023 Nov; 12(1):137. PubMed ID: 38031155
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in Japan.
Igari H; Asano H; Murata S; Yoshida T; Kawasaki K; Kageyama T; Ikeda K; Koshikawa H; Okuda Y; Urushihara M; Chiba H; Yahaba M; Taniguchi T; Matsushita K; Yoshino I; Yokote K; Nakajima H
J Infect Chemother; 2022 Nov; 28(11):1483-1488. PubMed ID: 35870791
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
7. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
Cegolon L; Negro C; Mastrangelo G; Filon FL;
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
[No Abstract] [Full Text] [Related]
8. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers.
Bansal A; Trieu MC; Mohn KGI; Madsen A; Olofsson JS; Sandnes HH; Sævik M; Søyland H; Hansen L; Onyango TB; Tøndel C; Brokstad KA; ; Syre H; Riis ÅG; Langeland N; Cox RJ
Front Public Health; 2023; 11():1164326. PubMed ID: 37546332
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.
Hodgson D; Colton H; Hornsby H; Brown R; Mckenzie J; Bradley KL; James C; Lindsey BB; Birch S; Marsh L; Wood S; Bayley M; Dickson G; James DC; Nicklin MJH; Sayers JR; Zafred D; Rowland-Jones SL; Kudesia G; Kucharski A; ; Darton TC; de Silva TI; Collini PJ
medRxiv; 2021 Jul; ():. PubMed ID: 34268521
[TBL] [Abstract][Full Text] [Related]
10. Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
Stellini R; Gianello R; Gomarasca W
Infection; 2022 Dec; 50(6):1573-1577. PubMed ID: 35391649
[TBL] [Abstract][Full Text] [Related]
11. Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study.
Woolf K; McManus IC; Martin CA; Nellums LB; Guyatt AL; Melbourne C; Bryant L; Gogoi M; Wobi F; Al-Oraibi A; Hassan O; Gupta A; John C; Tobin MD; Carr S; Simpson S; Gregary B; Aujayeb A; Zingwe S; Reza R; Gray LJ; Khunti K; Pareek M;
Lancet Reg Health Eur; 2021 Oct; 9():100180. PubMed ID: 34308406
[TBL] [Abstract][Full Text] [Related]
12. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
Özgür D; Tütüncü EE
Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
Int J Infect Dis; 2021 Dec; 113():15-17. PubMed ID: 34614445
[TBL] [Abstract][Full Text] [Related]
14. Primary Series and Booster Coronavirus Disease 2019 Vaccine Effectiveness in a Cohort of Healthcare Workers in Albania During a BA.1 and BA.2 Variant Period, January-May 2022.
Finci I; Rojas Castro MY; Hasibra I; Sulo J; Fico A; Daja R; Vasili A; Kota M; Preza I; Mühlemann B; Drosten C; Pebody R; Lafond KE; Kissling E; Katz MA; Bino S
Open Forum Infect Dis; 2023 Oct; 10(10):ofad479. PubMed ID: 37885795
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data.
Sridhar S; Fico A; Preza I; Hatibi I; Sulo J; Kissling E; Daja R; Ibrahim R; Lemos D; Rubin-Smith J; Schmid A; Vasili A; Valenciano M; Jorgensen P; Pebody R; Lafond KE; Katz MA; Bino S
BMJ Open; 2022 Mar; 12(3):e057741. PubMed ID: 35321895
[TBL] [Abstract][Full Text] [Related]
16. The Longitudinal Analysis on the Anti-SARS-CoV-2 Antibodies among Healthcare Workers in Poland-Before and after BNT126b2 mRNA COVID-19 Vaccination.
Lorent D; Nowak R; Luwański D; Pisarska-Krawczyk M; Figlerowicz M; Zmora P
Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298441
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study.
Taher WT; Bawazir AA; Sallam TA; Alsurimi K
BMC Infect Dis; 2023 Nov; 23(1):761. PubMed ID: 37932664
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
[TBL] [Abstract][Full Text] [Related]
19. Anti-SARS-CoV-2 Antibodies Level and COVID-19 Vaccine Boosters among Healthcare Workers with the Highest SARS-CoV-2 Infection Risk-Follow Up Study.
Lorent D; Nowak R; Figlerowicz M; Handschuh L; Zmora P
Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793726
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
Cegolon L; Magnano G; Negro C; Larese Filon F;
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
